136 related articles for article (PubMed ID: 37679967)
1. Association between CTLA4 + 49A/G polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
Tan X; Liu C; Sun L
Nucleosides Nucleotides Nucleic Acids; 2024; 43(4):302-315. PubMed ID: 37679967
[TBL] [Abstract][Full Text] [Related]
2. Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese.
Wang C; Liu W; Zhao L; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1117-S1120. PubMed ID: 30539855
[TBL] [Abstract][Full Text] [Related]
3. A deeper understanding of the association between CTLA4 +49A/G and acute rejection in renal transplantation: an updated meta-analysis.
Gao JW; Zhou ZH; Guo SC; Guo YF; Guo F
Ren Fail; 2015 Feb; 37(1):165-74. PubMed ID: 25299395
[TBL] [Abstract][Full Text] [Related]
4. Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.
Yang J; Liu J; Chen Y; Tang W; Liu C; Sun Y; Chen J
Medicine (Baltimore); 2019 Jul; 98(29):e16266. PubMed ID: 31335675
[TBL] [Abstract][Full Text] [Related]
5. [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
Liu G; Lu GX
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1838-40. PubMed ID: 20813679
[TBL] [Abstract][Full Text] [Related]
6. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
[TBL] [Abstract][Full Text] [Related]
7. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
9. MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis.
Qiu D; Han F; Zhuang H
J Cancer Res Ther; 2018 Jun; 14(Supplement):S490-S493. PubMed ID: 29970712
[TBL] [Abstract][Full Text] [Related]
10. The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto's thyroiditis in Asian but not Caucasian populations: an updated meta-analysis.
Feng M; Zhang FB; Deng HR
Endocrine; 2013 Oct; 44(2):350-8. PubMed ID: 23860622
[TBL] [Abstract][Full Text] [Related]
11. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
[No Abstract] [Full Text] [Related]
12. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ +874A/T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Zhou H; Wang L; Li X; Song J; Jiang T; Wu X; Zhou S
Med Sci Monit; 2015 Mar; 21():689-93. PubMed ID: 25739411
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.
Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D
Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867
[TBL] [Abstract][Full Text] [Related]
16. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
[TBL] [Abstract][Full Text] [Related]
17. The association of common functional polymorphisms in mir-146a and mir-196a2 and hepatocellular carcinoma risk: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Deng Y; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e252. PubMed ID: 25546664
[TBL] [Abstract][Full Text] [Related]
18. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun H; Han B; Zhai H; Cheng X; Ma K
Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
[TBL] [Abstract][Full Text] [Related]
19. Association of cytotoxic T-lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation.
Yang CH; Chen XX; Chen L; Zheng DH; Liu QS; Xie WF
Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28333403
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the association between CTLA-4 genetic polymorphism and susceptibility of asthma.
Zheng Y; Wang H; Luo L; Liao L; You L; Wang J; Li Q
Medicine (Baltimore); 2018 Jul; 97(28):e11380. PubMed ID: 29995780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
